Login

April Ingram

ORCID: 0000-0003-4959-8819
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
A5003690018
Research Areas
  • Retinal and Optic Conditions
  • Childhood Cancer Survivors' Quality of Life
  • Acute Lymphoblastic Leukemia research
  • Retinal Development and Disorders
  • Neuroblastoma Research and Treatments
  • Retinal Diseases and Treatments

Menlo School
 2023

The University of Texas MD Anderson Cancer Center
 2020

 Long-term Follow-up of a Phase 1/2a Clinical Trial of a Stem Cell-Derived Bioengineered Retinal Pigment Epithelium Implant for Geographic Atrophy
OPENALEX - Publications 
Mark S. Humayun Dennis Clegg Margot S. Dayan Amir H. Kashani Firas M. Rahhal and 13 more Robert L. Avery Hani Salehi-Had Sanford Chen Clement K. Chan Neal Palejwala April Ingram Debbie Mitra Britney O. Pennington Cassidy Hinman Mohamed A. Faynus Jeff Bailey Lincoln V. Johnson Jane Lebkowski

10.1016/j.ophtha.2023.12.028 article EN Ophthalmology 2023-12-30
 Phase 2 study of hyper‐CMAD with liposomal vincristine for patients with newly diagnosed acute lymphoblastic leukemia
OPENALEX - Publications 
Koji Sasaki Hagop M. Kantarjian William G. Wierda Farhad Ravandi‐Kashani Jeffrey L. Jorgensen and 20 more Sa A. Wang Joseph D. Khoury Naval Daver Jan A. Burger Courtney D. Di Nardo Nitin Jain Nicholas J. Short Zeev Estrov Marina Konopleva Maro Ohanian Guillermo Garcia‐Manero Tapan M. Kadia Yesid Alvarado‐Valero Musa Yılmaz Sherry Pierce Rebecca Garris April Ingram Jorge E. Cortés Susan O’Brien Elias Jabbour

Liposomal vincristine is designed to reduce neurotoxicity and increase dose intensity delivery, has been approved as salvage therapy in relapsed/refractory acute lymphoblastic leukemia (ALL). Our aim was evaluate the response rate, toxicities, outcome of adults with newly diagnosed ALL who received liposomal vincristine, rather than regular combination intensive chemotherapy (Hyper-CMAD). In a single-center, phase 2 study, patients ≥18 years newly-diagnosed B-cell were eligible receive...

10.1002/ajh.25784 article EN American Journal of Hematology 2020-03-14
Coming Soon ...